Biomedicines
Cytotoxicity of Cannabinoids in Combination with Traditional Lymphoma Chemotherapeutic Drugs Against Non-Hodgkin's Lymphoma.
Saba Omer, Mahmoud Mansour, Satyanarayana R Pondugula, Muralikrishnan Dhanasekaran, Brad Matz, Omer Khan, Dawn Boothe
Published: 202510.3390/biomedicines14010003
Abstract
Background: Cannabinoids (CBs) are FDA-approved for mitigating chemotherapy-induced side effects such as pain, nausea, and loss of appetite. Beyond palliative care, CBs exhibit anti-tumor properties in various cancers, including non-Hodgkin's lymphom…
Preview only. Read the full abstract at the source